Comparative Study Between Combined Vaginal Misoprostol

NCT04981457 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-07-29

No results posted yet for this study

Summary

"Comparative study between Combined Vaginal Misoprostol with Isosorbide-5-Mononitrate

Conditions

  • Missed Abortion

Interventions

DRUG

Misoprostol and iso sorbide mononitrates

drug

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • mohamed shalaby, MD · Cairo u

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-02
Primary Completion
2021-09-30
Completion
2021-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04981457 on ClinicalTrials.gov